Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VST vs MRNA✓SelectedUSD · MRNAVST vs MRNA performance historyLatest closeAs of-1.23%11/18
Stock and ETF performance explorer

VST vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+582.5%
MRNA return
-25.9%
Excess return
+608.3%
Maximum drawdown
-48.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.2%-4.8%+3.6%-1.0%
7D-5.9%-20.9%+15.0%-5.0%
30D-16.1%-13.3%-2.8%-15.7%
3M-10.5%+212.6%-223.0%-17.0%
6M-7.9%+309.0%-316.9%-17.0%
YTD-21.8%+567.3%-589.1%-33.1%
1Y-27.6%+689.7%-717.3%-39.2%
3Y+269.6%+157.4%+112.1%+230.4%
All+582.5%-25.9%+608.3%+508.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling